DK2217729T3 - Fremgangsmåde til koncentrering af nukleinsyremolekyler - Google Patents
Fremgangsmåde til koncentrering af nukleinsyremolekyler Download PDFInfo
- Publication number
- DK2217729T3 DK2217729T3 DK08857258.1T DK08857258T DK2217729T3 DK 2217729 T3 DK2217729 T3 DK 2217729T3 DK 08857258 T DK08857258 T DK 08857258T DK 2217729 T3 DK2217729 T3 DK 2217729T3
- Authority
- DK
- Denmark
- Prior art keywords
- nucleic acid
- molecules
- molecule
- magnetic
- magnetic beads
- Prior art date
Links
- 150000007523 nucleic acids Chemical class 0.000 title claims description 170
- 102000039446 nucleic acids Human genes 0.000 title claims description 156
- 108020004707 nucleic acids Proteins 0.000 title claims description 156
- 238000000034 method Methods 0.000 title claims description 107
- 230000005291 magnetic effect Effects 0.000 claims description 146
- 239000011324 bead Substances 0.000 claims description 101
- 238000000018 DNA microarray Methods 0.000 claims description 57
- 230000027455 binding Effects 0.000 claims description 36
- 238000012546 transfer Methods 0.000 claims description 33
- 238000002844 melting Methods 0.000 claims description 29
- 230000008018 melting Effects 0.000 claims description 29
- 108020004414 DNA Proteins 0.000 description 100
- 230000008569 process Effects 0.000 description 75
- 108091034117 Oligonucleotide Proteins 0.000 description 61
- 239000000523 sample Substances 0.000 description 54
- 102000053602 DNA Human genes 0.000 description 51
- 239000000463 material Substances 0.000 description 44
- 239000002245 particle Substances 0.000 description 35
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 28
- 238000001514 detection method Methods 0.000 description 26
- 238000009396 hybridization Methods 0.000 description 23
- 102000004169 proteins and genes Human genes 0.000 description 21
- 230000000295 complement effect Effects 0.000 description 19
- 239000000243 solution Substances 0.000 description 18
- 238000003752 polymerase chain reaction Methods 0.000 description 17
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 16
- 108090000623 proteins and genes Proteins 0.000 description 16
- 239000003995 emulsifying agent Substances 0.000 description 15
- 239000012071 phase Substances 0.000 description 15
- 239000006249 magnetic particle Substances 0.000 description 12
- 229920000642 polymer Polymers 0.000 description 11
- 229920002451 polyvinyl alcohol Polymers 0.000 description 11
- 239000013615 primer Substances 0.000 description 11
- 239000004372 Polyvinyl alcohol Substances 0.000 description 10
- -1 nucleoside triphosphates Chemical class 0.000 description 10
- 230000008901 benefit Effects 0.000 description 9
- 239000000084 colloidal system Substances 0.000 description 9
- 239000003446 ligand Substances 0.000 description 9
- 241000894007 species Species 0.000 description 9
- 229960002685 biotin Drugs 0.000 description 8
- 235000020958 biotin Nutrition 0.000 description 8
- 239000011616 biotin Substances 0.000 description 8
- 210000004027 cell Anatomy 0.000 description 8
- 108091028043 Nucleic acid sequence Proteins 0.000 description 7
- 241000700605 Viruses Species 0.000 description 7
- 239000000203 mixture Substances 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- 239000007787 solid Substances 0.000 description 7
- 239000003921 oil Substances 0.000 description 6
- 229920001223 polyethylene glycol Polymers 0.000 description 6
- 238000000926 separation method Methods 0.000 description 6
- 230000009870 specific binding Effects 0.000 description 6
- 238000005406 washing Methods 0.000 description 6
- 108091005461 Nucleic proteins Proteins 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 238000010168 coupling process Methods 0.000 description 5
- 238000005859 coupling reaction Methods 0.000 description 5
- 238000011161 development Methods 0.000 description 5
- 230000018109 developmental process Effects 0.000 description 5
- 238000009826 distribution Methods 0.000 description 5
- 239000007850 fluorescent dye Substances 0.000 description 5
- 238000011534 incubation Methods 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 239000000725 suspension Substances 0.000 description 5
- 229920001400 block copolymer Polymers 0.000 description 4
- 230000008878 coupling Effects 0.000 description 4
- 239000011521 glass Substances 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 239000000758 substrate Substances 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 239000002202 Polyethylene glycol Substances 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 239000012472 biological sample Substances 0.000 description 3
- 239000007853 buffer solution Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000004925 denaturation Methods 0.000 description 3
- 230000036425 denaturation Effects 0.000 description 3
- 238000013461 design Methods 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 230000005684 electric field Effects 0.000 description 3
- 238000002955 isolation Methods 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 239000002987 primer (paints) Substances 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 239000007790 solid phase Substances 0.000 description 3
- 108091023037 Aptamer Proteins 0.000 description 2
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 2
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 2
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- 229920001214 Polysorbate 60 Polymers 0.000 description 2
- 102000007562 Serum Albumin Human genes 0.000 description 2
- 108010071390 Serum Albumin Proteins 0.000 description 2
- 108010090804 Streptavidin Proteins 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
- 239000004359 castor oil Substances 0.000 description 2
- 230000001351 cycling effect Effects 0.000 description 2
- 238000009792 diffusion process Methods 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 150000002194 fatty esters Chemical class 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 230000003100 immobilizing effect Effects 0.000 description 2
- 238000003018 immunoassay Methods 0.000 description 2
- 230000002452 interceptive effect Effects 0.000 description 2
- 239000007791 liquid phase Substances 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 238000004377 microelectronic Methods 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 238000007899 nucleic acid hybridization Methods 0.000 description 2
- 239000002777 nucleoside Substances 0.000 description 2
- 239000002773 nucleotide Substances 0.000 description 2
- 125000003729 nucleotide group Chemical group 0.000 description 2
- 230000005298 paramagnetic effect Effects 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 229920001983 poloxamer Polymers 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 230000002441 reversible effect Effects 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 238000002198 surface plasmon resonance spectroscopy Methods 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 239000001226 triphosphate Substances 0.000 description 2
- 235000011178 triphosphate Nutrition 0.000 description 2
- 238000009827 uniform distribution Methods 0.000 description 2
- FDCJDKXCCYFOCV-UHFFFAOYSA-N 1-hexadecoxyhexadecane Chemical class CCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCC FDCJDKXCCYFOCV-UHFFFAOYSA-N 0.000 description 1
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 108020003215 DNA Probes Proteins 0.000 description 1
- 239000003155 DNA primer Substances 0.000 description 1
- 239000003298 DNA probe Substances 0.000 description 1
- 229920005682 EO-PO block copolymer Polymers 0.000 description 1
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- 108090001090 Lectins Proteins 0.000 description 1
- 102000004856 Lectins Human genes 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 1
- RVGRUAULSDPKGF-UHFFFAOYSA-N Poloxamer Chemical compound C1CO1.CC1CO1 RVGRUAULSDPKGF-UHFFFAOYSA-N 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 241000854711 Shinkai Species 0.000 description 1
- 108020004682 Single-Stranded DNA Proteins 0.000 description 1
- 229920002359 Tetronic® Polymers 0.000 description 1
- 101710120037 Toxin CcdB Proteins 0.000 description 1
- NWGKJDSIEKMTRX-BFWOXRRGSA-N [(2r)-2-[(3r,4s)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyethyl] (z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](O)C1OC[C@H](O)[C@H]1O NWGKJDSIEKMTRX-BFWOXRRGSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 238000001042 affinity chromatography Methods 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 230000000692 anti-sense effect Effects 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 229920001222 biopolymer Polymers 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 230000006037 cell lysis Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920006217 cellulose acetate butyrate Polymers 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000003196 chaotropic effect Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 239000000287 crude extract Substances 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 210000004292 cytoskeleton Anatomy 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical class OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 238000000835 electrochemical detection Methods 0.000 description 1
- 238000003411 electrode reaction Methods 0.000 description 1
- 125000003700 epoxy group Chemical group 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 210000003527 eukaryotic cell Anatomy 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000001943 fluorescence-activated cell sorting Methods 0.000 description 1
- 125000002485 formyl group Chemical class [H]C(*)=O 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 238000007306 functionalization reaction Methods 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 238000002032 lab-on-a-chip Methods 0.000 description 1
- 239000002523 lectin Substances 0.000 description 1
- 108010026228 mRNA guanylyltransferase Proteins 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 238000002493 microarray Methods 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 210000003463 organelle Anatomy 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 229920000191 poly(N-vinyl pyrrolidone) Polymers 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920000151 polyglycol Polymers 0.000 description 1
- 239000010695 polyglycol Substances 0.000 description 1
- 102000040430 polynucleotide Human genes 0.000 description 1
- 108091033319 polynucleotide Proteins 0.000 description 1
- 239000002157 polynucleotide Substances 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 210000001236 prokaryotic cell Anatomy 0.000 description 1
- 239000011241 protective layer Substances 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 230000003362 replicative effect Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 229910000077 silane Inorganic materials 0.000 description 1
- 238000005245 sintering Methods 0.000 description 1
- 239000012798 spherical particle Substances 0.000 description 1
- 239000010414 supernatant solution Substances 0.000 description 1
- 239000002344 surface layer Substances 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000009210 therapy by ultrasound Methods 0.000 description 1
- 150000003573 thiols Chemical class 0.000 description 1
- 125000002088 tosyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1C([H])([H])[H])S(*)(=O)=O 0.000 description 1
- GPRLSGONYQIRFK-MNYXATJNSA-N triton Chemical compound [3H+] GPRLSGONYQIRFK-MNYXATJNSA-N 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 239000007762 w/o emulsion Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6816—Hybridisation assays characterised by the detection means
- C12Q1/6825—Nucleic acid detection involving sensors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
- C12Q1/6837—Enzymatic or biochemical coupling of nucleic acids to a solid phase using probe arrays or probe chips
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
- Y10T436/142222—Hetero-O [e.g., ascorbic acid, etc.]
- Y10T436/143333—Saccharide [e.g., DNA, etc.]
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Claims (2)
1
1. Fremgangsmåde til koncentrering af nukleinsyremolekyler (5a, 5b) på en overflade (201) af et sensorfelt (103a) af en biochip, hvor fremgangsmåden omfatter de følgende trin at: 5 (a) tilvejebringe magnetiske perler (1), med overførselsmolekyler (3a, 3b, 3c) im- mobiliseret derpå, som er i stand til at hybridisere til en del af nukleinsyremolekylerne (5a, 5b), som derved danner komplekser, som omfatter de magnetiske perler (1), overførselsmolekylerne (3a, 3b, 3c) og nukleinsyremolekylerne; tilvejebringe en overflade (201) af et sensorfelt (103a, 103b, 103c), som danner en 10 del af en overflade (101) af en biochip, hvor indfangningsmolekyler (203) er immobiliseret på overfladen (201), hvor indfangningsmolekylerne (203) specifikt hybridiserer til en del af nukleinsyremolekylerne (5a, 5b), hvor nukleinsyresekvenserne af indfangningsmolekylerne (203) og overførselsmolekylerne (3a, 3b, 3c) er valgt på en sådan måde at smeltetemperaturen af hybridet mellem et nukleinsyremolekyle (5a, 5b) og et overførselsmolekyle (3a, 15 3b, 3c) er mindre end smeltetemperaturen af hybridet mellem et nukleinsyremolekyle (5a, 5b) og et indfangningsmolekyle (203); og tilvejebringe en magnetisk feltgenerator (105); (b) inkubere de magnetiske perler (1) med nukleinsyremolekylerne (5a, 5b) ved en temperatur TI, som er under smeltetemperaturen af hybriderne mellem nukleinsyremole- 20 kylerne (5a, 5b) og overførselsmolekylerne (3a, 3b), som derved tillader nukleinsyremolekylerne (5a, 5b) at hybridisere til overførselsmolekylerne (3a, 3b); (c) at benytte et magnetisk felt gennem den magnetiske feltgenerator (105), som derved flytter nukleinsyremolekylerne (5a, 5b) bundet til de magnetiske perler (1) gennem det magnetisk felt til overfladen (101) af biochippen, som derved bringer nukleinsyremole- 25 kylerne (5a, 5b) bundet til de magnetiske perler (1) i kontakt med en overflade (201) af sensorfeltet (103a, 103b); (d) øge temperaturen fra en temperatur TI til en temperatur T2, som er over smeltetemperaturen af hybriderne af nukleinsyremolekylerne (5a, 5b) og overførselsmolekylerne (3a, 3b), og som er under smeltetemperaturen af hybriderne af nukleinsyremolekylerne 30 (5a, 5b) og indfangningsmolekylerne (203), som derved opløser nukleinsyremolekylerne (5a) fra de magnetiske perler (1) og tillade binding af mindst én del af nukleinsyremolekylerne (5a, 5b) til indfangningsmolekylet (203); (e) flytte de magnetiske perler (1) væk fra overfladen (101) af biochippen ved at afbryde det magnetiske field; 35 (f) gentage trinnene (b) til (e).
2. Fremgangsmåde ifølge krav 1, hvor forskellige specier af magnetiske perler (1) er tilvejebragt, hvor hver magnetisk perle, der har ét specifikt overførselsmolekyle (3a, 3b, 3c) immobiliseret derpå, som er i stand til at binde til et specifikt nukleinsyremolekyle (5a, 5b), som detekteres.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP07023377A EP2067867A1 (en) | 2007-12-03 | 2007-12-03 | Process for concentrating nucleic acid molecules |
| PCT/EP2008/064876 WO2009071404A1 (en) | 2007-12-03 | 2008-11-03 | Process for concentrating nucleic acid molecules |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK2217729T3 true DK2217729T3 (da) | 2015-08-24 |
Family
ID=39027540
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK08857258.1T DK2217729T3 (da) | 2007-12-03 | 2008-11-03 | Fremgangsmåde til koncentrering af nukleinsyremolekyler |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US8975017B2 (da) |
| EP (2) | EP2067867A1 (da) |
| CN (1) | CN101932730B (da) |
| DK (1) | DK2217729T3 (da) |
| ES (1) | ES2545584T3 (da) |
| WO (1) | WO2009071404A1 (da) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8815610B2 (en) | 2010-10-15 | 2014-08-26 | International Business Machines Corporation | Magnetic nanoparticle detection across a membrane |
| US10519487B2 (en) | 2016-08-18 | 2019-12-31 | City University Of Hong Kong | Kit and a method for determining the presence or amount of a target nucleic acid sequence in a sample |
| WO2019157191A1 (en) * | 2018-02-07 | 2019-08-15 | Georgia Tech Research Corporation | Methods for multiplexed cell isolation using dna gates |
| WO2025137866A1 (zh) * | 2023-12-26 | 2025-07-03 | 深圳华大智造科技股份有限公司 | 一种用于上机测序的含核酸溶液的回收利用方法 |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NO155316C (no) | 1982-04-23 | 1987-03-11 | Sintef | Fremgangsmaate for fremstilling av magnetiske polymerpartikler. |
| DE4127657B4 (de) | 1991-08-21 | 2008-03-13 | Chemagen Biopolymer-Technologie Aktiengesellschaft | Perlförmige Polyvinylalkoholgele für die Aufreinigung und Auftrennung biologischer Flüssigkeiten, Verfahren zu ihrer Herstellung und Verwendung |
| US5445971A (en) * | 1992-03-20 | 1995-08-29 | Abbott Laboratories | Magnetically assisted binding assays using magnetically labeled binding members |
| DE19520398B4 (de) | 1995-06-08 | 2009-04-16 | Roche Diagnostics Gmbh | Magnetisches Pigment |
| DE19528029B4 (de) | 1995-07-31 | 2008-01-10 | Chemagen Biopolymer-Technologie Aktiengesellschaft | Magnetische Polymerpartikel auf der Basis von Polyvinylalkohol, Verfahren für ihre Herstellung und Verwendung |
| AU3616497A (en) | 1996-07-26 | 1998-02-20 | Michael T. Kelly | Cyclic decapeptide antibiotics |
| EP0975807B1 (en) * | 1997-05-02 | 2006-09-27 | Gen-Probe Incorporated | Two-step hybridization and capture of a polynucleotide |
| US20020166764A1 (en) | 1997-08-12 | 2002-11-14 | University Of Southern California | Electrochemical sensor devices and methods for fast, reliable, and sensitive detection and quantitation of analytes |
| JP2002536660A (ja) | 1999-02-11 | 2002-10-29 | ユニバーシティ・オブ・サザン・カリフォルニア | 酵素結合の免疫磁気性電気化学的バイオセンサー |
| DE10013995A1 (de) | 2000-03-22 | 2001-09-27 | Chemagen Biopolymer Technologi | Magnetische, silanisierte Trägermaterialien auf Basis von Polyvinylalkohol |
| EP1360323A4 (en) * | 2000-09-20 | 2007-07-18 | Datascope Investment Corp | NUCLEIC ACID DETECTION |
| DE10111520B4 (de) | 2001-03-09 | 2004-01-15 | Chemagen Biopolymer-Technologie Aktiengesellschaft | Verfahren zur Aufreinigung von Biomolekülen mit Hilfe magnetischer Partikel |
| US20060040286A1 (en) * | 2001-03-28 | 2006-02-23 | Nanosphere, Inc. | Bio-barcode based detection of target analytes |
| US20030059823A1 (en) * | 2001-09-21 | 2003-03-27 | Juki Corporation | Hybridization apparatus and method for detecting nucleic acid in sample using the same |
| US20030186465A1 (en) | 2001-11-27 | 2003-10-02 | Kraus Robert H. | Apparatus used in identification, sorting and collection methods using magnetic microspheres and magnetic microsphere kits |
| JP2004184312A (ja) * | 2002-12-05 | 2004-07-02 | Yokogawa Electric Corp | 生体高分子検出方法およびバイオチップ |
| US7906345B2 (en) * | 2003-11-12 | 2011-03-15 | The Board Of Trustees Of The Leland Stanford Junior University | Magnetic nanoparticles, magnetic detector arrays, and methods for their use in detecting biological molecules |
| EP1880206B1 (en) * | 2005-05-09 | 2012-11-14 | Affymetrix, Inc. | Multiplex capture of nucleic acids |
| WO2007002567A2 (en) * | 2005-06-23 | 2007-01-04 | Nanosphere, Inc. | Selective isolation and concentration of nucleic acids from complex samples |
-
2007
- 2007-12-03 EP EP07023377A patent/EP2067867A1/en not_active Withdrawn
-
2008
- 2008-11-03 EP EP08857258.1A patent/EP2217729B1/en not_active Not-in-force
- 2008-11-03 CN CN200880126122.8A patent/CN101932730B/zh not_active Expired - Fee Related
- 2008-11-03 WO PCT/EP2008/064876 patent/WO2009071404A1/en not_active Ceased
- 2008-11-03 DK DK08857258.1T patent/DK2217729T3/da active
- 2008-11-03 US US12/734,934 patent/US8975017B2/en not_active Expired - Fee Related
- 2008-11-03 ES ES08857258.1T patent/ES2545584T3/es active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP2067867A1 (en) | 2009-06-10 |
| WO2009071404A1 (en) | 2009-06-11 |
| US8975017B2 (en) | 2015-03-10 |
| EP2217729A1 (en) | 2010-08-18 |
| CN101932730A (zh) | 2010-12-29 |
| EP2217729B1 (en) | 2015-06-03 |
| US20100248242A1 (en) | 2010-09-30 |
| CN101932730B (zh) | 2014-03-26 |
| ES2545584T3 (es) | 2015-09-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7408229B2 (ja) | ポリヌクレオチド捕捉材料およびその使用方法 | |
| US10458978B2 (en) | Miniaturized lateral flow device for rapid and sensitive detection of proteins or nucleic acids | |
| EP2644699B1 (en) | Amplified nucleic acid detection method and detection device | |
| US12559785B2 (en) | Analyte enrichment methods and compositions | |
| US20250145982A1 (en) | System and method for preparing a sequencing device | |
| WO2009137055A1 (en) | Nanocrystal-based lateral flow microarrays and low-voltage signal detection systems | |
| JP7843040B2 (ja) | 製作済み微粒子およびその前駆体のライブラリー | |
| JP2024527509A5 (da) | ||
| DK2217729T3 (da) | Fremgangsmåde til koncentrering af nukleinsyremolekyler | |
| JP6387606B2 (ja) | 核酸の検出方法 | |
| WO2010005444A1 (en) | Polynucleotide capture materials, and methods of using same |